This course has a start date in September
The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody- or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia. The course covers both antibody and vaccine cancer therapies and explores the immunology of the tumour host interface. In addition, students will learn about intellectual property and how to exploit scientific research in scientific writings, patents and in development of business plans applicable to the biotechnology industry. To gain practical experience in research students will carry out a research project in the field of tumour immunology.
Aims and Objectives:
- Acquire a specialised knowledge in tumour immunology with particular reference to monoclonal antibody and cancer vaccines
- Develop the critical and analytical power to evaluate scientific literature
- Perform a scientific research project
- Acquire the ability to communicate scientific results orally and in writing
- Learn about business exploitation of cancer therapy
Why choose this course?
If you are interested in learning about cancer immunotherapy, this is the only MSc course in the country that specialises entirely on this subject.